Ketorolac Tromethamine Injec · #11 of 35 active shortages by FDA posting duration
Brand: KETOROLAC TROMETHAMINE
FDA lists Ketorolac Tromethamine Injec as Active Shortage (Baxter Healthcare).
Availability on file: Available
Ketorolac Tromethamine Injection: Active Shortage
Available 25 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Ketorolac Tromethamine Injection
- Manufacturer
- Baxter Healthcare
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)
- Package NDC
- 0338-0069-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jun 6, 2018
- Last Updated
- Mar 4, 2026
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
ketorolac
Side effects, interactions, warnings & more
Nearby, Other Ketorolac Shortage Records
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Alembic Pharmaceuticals
Injection